CD101 Antibody, anti-mouse, REAlease®
Synonyms: EWI-101, Gm1016, Gm734, IGSF2
RECOMBINANT EXTENDED VALIDATION
Clone:
REAL172
Type of antibody:
Releasable antibodies, Primary antibodies, Recombinant antibodies
Applications:
FC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for CD101 Antibody, anti-mouse, REAlease®

Flow cytometry applications
APC
PE
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-116-229, 130-122-628
Description:
Splenocytes from C57BL6 mice were stained with REAlease CD101-APC (B) or with the corresponding REAL Control (A). REAlease CD101-APC was released using the REAlease Release Reagent (C). To show epitope accessibility after REAlease Complex release, the cells were washed with the REAlease Stop Reagent and restained with REAlease CD101-APC (D). Cells were labeled with Anti-Ly-6G antibodies in addition and analyzed by flow cytometry using the MACSQuant® Analyzer. Cell debris and dead cells were excluded from the analysis based on scatter signals and propidium iodide (PI) fluorescence.

Application imageView details view details

Application imageView details view details

Application imageView details view details

Application imageView details view details
Extended validation for CD101 Antibody, anti-mouse, REAlease®
Sensitivity
Fixation data

To provide an indication on how an antibody performs after fixation of cells, in-house data on staining results before and after fixation with 3.7% formaldehyde using Miltenyi Biotec antibodies are provided. Different experimental settings may lead to different results.

No fixation
Extended-Validation detailed information image
Post fixation
Extended-Validation detailed information image
Extended-Validation detailed information image
Extended-Validation detailed information image

Comparison of staining pattern on non-fixed and fixed cells using CD101 (REAL172). The performance of the antibody after fixation was tested by comparing the staining pattern on fresh (no fixation) versus fixed (post fixation) cells.

Specifications for CD101 Antibody, anti-mouse, REAlease®
Overview

Clone REAL172 is an antibody fragment derived from the full CD101 antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAlease Complex to bind markers with high avidity.

Clone REAL172 recognizes the mouse CD101 antigen, a type I transmembrane glycoprotein also known as Immunoglobulin superfamily member 2 (IgSF2) or V7. CD101 is expressed on monocytes, granulocytes, dendritic cells (DCs), and activated T cells. In humans CD101 inhibits the proliferative response of T cells to allogeneic cells or immobilized anti-CD3 antibody, suggesting that engagement of CD101 can antagonize TCR/CD3-mediated lymphocyte activation. Moreover, human peripheral CD8+ T cells that express CD101 and CD103 display suppressive function after activation with intraepithelial cells or placental trophoblasts. In addition to its role on T cells, triggering CD101 on human cutaneous DC inhibits T cell proliferation via interleukin 10 (IL-10) production, suggesting that the CD101 molecule may be involved in tolerance induction. Studies in mice showed that cell surface expression of CD101 is highly correlated with functional suppressor activity within CD4+CD25+ regulatory T cells both in vitro and in vivo.

The REAlease Kits consist of the respective fluorochrome-conjugated REAlease Complexes and the REAlease Support Kit for removal of the REAlease Complexes and optional relabeling with different fluorochrome-conjugated REAlease Complexes.

Alternative names

EWI-101, Gm1016, Gm734, IGSF2

Detailed product information

Technical specifications

Clone
REAL172
Clonality
monoclonal
Isotype control
Control Antibody
Host
cell line
Type of antibody
Releasable antibodies, Primary antibodies, Recombinant antibodies
Species reactivity
mouse
Antigen
CD101
Distribution of antigen
monocytes, granulocytes, dendritic cells, T cells
RRID
AB_2751582, AB_2783896, AB_2783897, AB_2751313
Resources for CD101 Antibody, anti-mouse, REAlease®
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

Citations for CD101 Antibody, anti-mouse, REAlease®
Publications
  1. Fernandez, I. et al. (2007) CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells. J Immunol 179 (5): 2808-2814
  2. Mohammed, J. P. et al. (2011) Identification of CD101 as a susceptibility gene for Novosphingobium aromaticivorans-induced liver autoimmunity. J Immunol 187 (1): 337-349
  3. Penha-Gonçalves, C. et al. (2003) Identification of a structurally distinct CD101 molecule encoded in the 950-kb Idd10 region of NOD mice. Diabetes 52 (6): 1551-1556